Interpace Biosciences, Inc. (IDXG) Financials

IDXG Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 14.3 million 76.9 million
2023-06-30 15.9 million 78.1 million
2023-03-31 15.9 million 78.4 million
2022-12-31 16.0 million 79.1 million

IDXG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 ? ?
2023-06-30 300000 157000
2023-03-31 1.1 million 192000
2022-12-31 -472000 125000

IDXG Net Income

No data available :(

IDXG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - 2.0 million
2023-06-30 - - 2.1 million
2023-03-31 - - 2.3 million
2022-12-31 - - 2.4 million

IDXG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.3 million
2023-06-30 4.3 million
2023-03-31 4.3 million
2022-12-31 4.3 million

IDXG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - - - -
2023-06-30 111000 186000 5.5 million -
2023-03-31 111000 149000 4.8 million -
2022-12-31 7.6 million 77000 4.5 million -

IDXG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 11.0 million 4.2 million
2023-03-31 9.8 million 3.8 million
2022-12-31 8.3 million 3.3 million

IDXG

Price: $1.41

52 week price:
0.62
3.54

Earnings Per Share: -0.43 USD

P/E Ratio: -2.17

Exchange: PNK

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1193

Ebitda: -2.5 million

Market Capitalization: 6.3 million

Links: